Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes

References

1. Arenzana-Seisdedos F., Israel N., Bachelerie F., Hazan U., Alcami J., Dautry F., Virelizier J.-L. 1989; c-Ha-ras transfection induces human immunodeficiency virus (HIV) tran-scription through the HIV enhancer in human fibroblasts and astrocytes. Oncogene 4:1359–1362
   [Google Scholar]
2. Barbacid M. 1987; ras genes. Annual Review of Biochemistry 56:779–827
   [Google Scholar]
3. Bishop J. M. 1985a; Viral oncogenes. Cell 42:23–38
   [Google Scholar]
4. Bishop J. M. 1985b; Trends in oncogenes. Trends in Genetics 1:245–249
   [Google Scholar]
5. Boldogh I., Abubakar S., Deng C. Z., Albrecht T. 1991a; Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. Journal of Virology 65:1568–1573
   [Google Scholar]
6. Boldogh I., Abubakar S., Millinoff D., Deng C. Z., Albrecht T. 1991b; Cellular oncogene activation by human cytomegalovirus, lack of correlation with virus infectivity and immediate early gene expression. Archives of Virology 118:163–177
   [Google Scholar]
7. Bortner D. M., Langer S. J., Ostrowski M. C. 1993; Nonnuclear oncogenes and the regulation of gene expression in transformed cells. Critical Reviews in Oncogenesis 4:137–160
   [Google Scholar]
8. Cai H., Szeberenyi J., Cooper G. M. 1990; Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Molecular and Cellular Biology 10:5314–5323
   [Google Scholar]
9. Chin K.-V., Ueda K., Pastan I., Gottesman M. M. 1992; Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459–462
   [Google Scholar]
10. Chirgwin J. M., Przybyla A. E., Macdonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
    [Google Scholar]
11. Dominguez I., Sanz L., Arenzana-Seisdedox F., Diaz-Meco M. T., Virelizier J.-L., Moscat J. 1993; Inhibition of protein kinase C ζ subspecies blocks the activation of an NF-kB-like activity in Xenopus laevis oocytes. Molecular and Cellular Biology 13:1290–1295
    [Google Scholar]
12. Dorsch-Hasler K., Keil G. M., Weber F., Jasin M., Schaffner W., Koszinowski U. H. 1985; A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 82:8325–8329
    [Google Scholar]
13. Dotto G. P., Parada L. F., Weinberg R. A. 1985; Specific growth response of ras-transformed embryo fibroblasts to tumour promoters. Nature; London: 318472–475
    [Google Scholar]
14. Downward J. 1992; Regulatory mechanisms for ras proteins. BioEssays 14:177–184
    [Google Scholar]
15. Ebeling M., Keil G. M., Knust E., Koszinowski U. H. 1983; Molecular cloning and physical mapping of murine cytomegalovirus DNA. Journal of Virology 47:412–433
    [Google Scholar]
16. Feig L. A., Cooper G. M. 1988; Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Molecular and Cellular Biology 8:3235–3243
    [Google Scholar]
17. Galien R., Mercier G., Garcette M., Emanoil-Ravier R. 1991; RAS oncogene activates the intracisternalA particle long terminal repeat promoter through a c-AMP response element. Oncogene 6:849–855
    [Google Scholar]
18. Gorman C. M., Moffat L. F., Howard B. H. 1982; Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
19. Gribaudo G., Ravaglia S., Caliendo A., Cavallo R., Gariglio M., Martinotti M. G., Landolfo S. 1993; Interferons inhibit the onset of murine cytomegalovirus immediate-early gene transcription. Virology in press
    [Google Scholar]
20. Hall C., Jacob E., Ringold G., Lee F. 1983; Expression and regulation of Escherichia colt lacZ gene fusion in mammalian cells. Journal of Molecular and Applied Genetics 2:101–109
    [Google Scholar]
21. Hudson J. B. 1979; The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archives of Virology 62:1–29
    [Google Scholar]
22. Imler J. L., Schartz C., Wasylyk C., Chatton B., Wasylyk B. 1988; A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum. Nature; London: 332275–278
    [Google Scholar]
23. Kedar P. S., Lowry D. R., Widen S. G., Wilson S. H. 1990; Transfected human b-polymerase promoter contains a ras-responsive element. Molecular and Cellular Biology 10:3852–3856
    [Google Scholar]
24. Keil G. M., Ebeling-Keil A., Koszinowski U. H. 1987; Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. Journal of Virology 61:1901–1908
    [Google Scholar]
25. Koszinowski U. H., Del Val M., Reddehase M. J. 1990; Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Current Topics in Microbiology and Immunology 154:189–220
    [Google Scholar]
26. Mcdougall J. K. 1990 Cytomegaloviruses Berlin: Springer-Verlag;
    [Google Scholar]
27. Manning W. C., Mocarski E. S. 1988; Insertional mutagenesis of the murine cytomegalovirus genome: one prominant gene (ie2) is dispensable for growth. Virology 167:477–484
    [Google Scholar]
28. Marx J. 1993; Forging a path to the nucleus. Science 260:1588–1590
    [Google Scholar]
29. Medema R. H., Wubbolts R., Bos J. L. 1991; Two dominant inhibitory mutants of p21^ras interfere with insulin-induced gene expression. Molecular and Cellular Biology 11:5963–5967
    [Google Scholar]
30. Mercer J. A., Marks J. R., Spector D. H. 1983; Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain). Virology 129:94–106
    [Google Scholar]
31. Messerle M., Buhler B., Keil G. M., Koszinowski U. H. 1992; Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. Journal of Virology 66:27–36
    [Google Scholar]
32. Mocarski E. S. 1991; Initial events involved in cytomegalovirus-cell interactions. Transplantation Proceedings 23:43–47
    [Google Scholar]
33. Moch H., Lang D., Stamminger T. 1992; Strong trans activation of the human cytomegalovirus major immediate-early enhancer by p40^tax of human T cell leukemia virus type I via two repetitive tax-responsive sequence elements. Journal of Virology 66:7346–7354
    [Google Scholar]
34. Oku N., Kaibuchi K., Fukumoto Y., Hori Y., Fujioka H., Takai Y. 1990; Comparison of the mode of action of ras p21 with those of protein kinases A and C in the stimulation of gene expression in NIH/3T3 cells. FEBS Letters 269:148–156
    [Google Scholar]
35. Owen R., Ostrowski M. C. 1987; Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ra.v in NIH 3T3 cells. Molecular and Cellular Biology 7:2512–2520
    [Google Scholar]
36. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
37. Sambucetti L. C., Cherrington J. M., Wilkinson G. W. G., Mocarski E. S. 1989; NF-kB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EM BO Journal 8:4251–4258
    [Google Scholar]
38. Satake M., Tamotsu I., Ito I. 1988; Modulation of polyomavirus enhancer binding proteins by Ha -ras oncogene. Oncogene 3:69–78
    [Google Scholar]
39. Shelbourn S. L., Sissons J. G. P., Sinclair J. H. 1989; Expression of oncogenic ras in human teratocarcinoma cells induces partial differentiation and permissiveness for human cytomegalovirus infection. Journal of General Virology 70:367–374
    [Google Scholar]
40. Varmus H. E. 1984; The molecular genetics of cellular oncogenes. Annual Review of Genetics 18:553–612
    [Google Scholar]
41. Wasylyk C., Imler J. L., Perez-Mutul J., Wasylyk B. 1987; The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. Cell 48:525–534
    [Google Scholar]